ZA953673B - Stable crystalline (6S)- and (6R)- tetrahydrofolic acid - Google Patents
Stable crystalline (6S)- and (6R)- tetrahydrofolic acidInfo
- Publication number
- ZA953673B ZA953673B ZA953673A ZA953673A ZA953673B ZA 953673 B ZA953673 B ZA 953673B ZA 953673 A ZA953673 A ZA 953673A ZA 953673 A ZA953673 A ZA 953673A ZA 953673 B ZA953673 B ZA 953673B
- Authority
- ZA
- South Africa
- Prior art keywords
- tetrahydrofolic acid
- stable crystalline
- crystalline
- stable
- tetrahydrofolic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH144294A CH686369A5 (de) | 1994-05-09 | 1994-05-09 | Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA953673B true ZA953673B (en) | 1996-01-12 |
Family
ID=4210562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA953673A ZA953673B (en) | 1994-05-09 | 1995-05-08 | Stable crystalline (6S)- and (6R)- tetrahydrofolic acid |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6271374B1 (fr) |
| EP (1) | EP0682026B2 (fr) |
| JP (2) | JP3419585B2 (fr) |
| KR (1) | KR950032192A (fr) |
| CN (1) | CN1063444C (fr) |
| AT (1) | ATE188699T1 (fr) |
| AU (1) | AU704363B2 (fr) |
| CA (1) | CA2148671C (fr) |
| CH (1) | CH686369A5 (fr) |
| DE (1) | DE59507591D1 (fr) |
| DK (1) | DK0682026T4 (fr) |
| ES (1) | ES2144066T5 (fr) |
| FI (1) | FI120585B (fr) |
| GR (1) | GR3032984T3 (fr) |
| HU (1) | HUT71612A (fr) |
| NO (1) | NO313673B1 (fr) |
| PT (1) | PT682026E (fr) |
| RU (1) | RU2165422C2 (fr) |
| ZA (1) | ZA953673B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689831A5 (de) * | 1995-11-07 | 1999-12-15 | Eprova Ag | Stabile kristalline Tetrahydrofolsaeure-Salze. |
| CH693905A5 (de) | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
| CH695217A5 (de) * | 1999-07-14 | 2006-01-31 | Merck Eprova Ag | Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure. |
| CH694251A5 (de) | 1999-07-14 | 2004-10-15 | Eprova Ag | Herstellung von Tetrahydropterin und Derivaten. |
| ITMI20020132A1 (it) | 2002-01-25 | 2003-07-25 | Gmt Fine Chemicals Sa | Processo per l'ottenimento dell'acido (6s)-5,6,7,8-tetraidrofolico |
| KR20070005550A (ko) | 2003-11-17 | 2007-01-10 | 바이오마린 파머수티컬 인크. | 대사 장애 치료를 위한 조성물 및 방법 |
| KR20060051135A (ko) * | 2004-09-15 | 2006-05-19 | 니프로 가부시키가이샤 | 안정화된 주사용 수용액 제재 |
| CA2588994A1 (fr) * | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methodes et compositions de traitement de l'hypertension pulmonaire du nouveau-ne |
| BR112012000614B1 (pt) | 2009-07-10 | 2022-05-24 | Linzy O. Scott Iii | Usos de folato no tratamento de hipotireoidismo e composições farmacêuticas compreendendo folato |
| US8372451B2 (en) * | 2010-02-12 | 2013-02-12 | Alexander Vuckovic, M.D., Llc | Compositions and methods for treating depression |
| JP5925381B2 (ja) * | 2012-04-13 | 2016-05-25 | ▲連雲▼港金康和信▲薬業▼有限公司Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. | 化合物[4−(2−アミノ−10−メチル−4−オキソ−6,7,8,9−テトラヒドロ−4a,7−エピミノピリミド[4,5−b][1,4]ジアゼピン−5(4H)−イル)ベンゾイル]−グルタメート及びその製造 |
| US9629846B1 (en) | 2013-11-14 | 2017-04-25 | Argent Development Group, Llc | Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| US9492421B1 (en) | 2013-11-14 | 2016-11-15 | Argent Development Group, Llc | Nutritional supplements for treatment of iron deficiency anemia |
| WO2016185413A1 (fr) | 2015-05-20 | 2016-11-24 | Nestec S.A. | Formulations à libération modifiée |
| US10059710B2 (en) | 2016-02-17 | 2018-08-28 | Merck & Cie | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid |
| AU2017397463B2 (en) | 2016-11-03 | 2022-01-06 | HedoniaUSA, Inc. | Compositions and methods for treating depression |
| US11185545B2 (en) | 2017-03-31 | 2021-11-30 | Merck Patent Gmbh | Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid |
| RU2019134064A (ru) | 2017-03-31 | 2021-04-30 | Мерк Патент Гмбх | Кристаллическая натриевая соль 5-метил-(6s)-тетрагидрофолиевой кислоты |
| EP4501315A1 (fr) | 2023-08-04 | 2025-02-05 | Lesaffre et Compagnie | Formulations liquides de folates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS497416A (fr) * | 1972-05-12 | 1974-01-23 | ||
| US4665176A (en) * | 1984-10-23 | 1987-05-12 | Mitsui Toatsu Chemicals, Incorporated | Process for the preparation of 5,6,7,8-tetrahydrofolic acid |
| GB8621268D0 (en) * | 1986-09-03 | 1986-10-08 | Univ Strathclyde | Separation of substances |
| CH673459A5 (fr) * | 1987-05-15 | 1990-03-15 | Eprova Ag | |
| DE3821875C1 (fr) * | 1988-06-29 | 1990-02-15 | Eprova Ag, Forschungsinstitut, Schaffhausen, Ch | |
| DK0432441T3 (da) * | 1989-12-11 | 1996-07-29 | American Cyanamid Co | Fremgangsmåde til fremstilling af optisk rene diastereoisomere af tetrahydrofolatforbindelser |
| CH680731A5 (fr) * | 1990-04-12 | 1992-10-30 | Sapec Fine Chemicals | |
| CH681303A5 (fr) * | 1991-01-16 | 1993-02-26 | Eprova Ag | |
| CH683261A5 (it) * | 1991-10-10 | 1994-02-15 | Applied Pharma Res | Procedimento per la preparazione dell'acido metiltetraidrofolico nella forma (6(R,S)(-))N-5 e separazione del diastereoisomero attivo (6(S)(-))N-5) sotto forma di sali. |
| US5198547A (en) * | 1992-03-16 | 1993-03-30 | South Alabama Medical Science Foundation, Usa | Process for N5-formylating tetrahydropteridines |
| US5698693A (en) * | 1992-11-16 | 1997-12-16 | The United States Of America As Represented By The Department Of Health And Human Services | Process of separating the diastereomers of (6R,6S) -5,6,7,8-tetrahydrofolic acid derivatives |
| CH686672A5 (de) * | 1992-12-01 | 1996-05-31 | Cerbios Pharma Sa | Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure. |
| AU2001268035A1 (en) | 2000-03-21 | 2001-10-03 | Bbj Environmental Solutions Inc. | Aqueous cleaning composition with controlled ph |
-
1994
- 1994-05-09 CH CH144294A patent/CH686369A5/de not_active IP Right Cessation
-
1995
- 1995-04-27 DK DK95106285T patent/DK0682026T4/da active
- 1995-04-27 EP EP95106285A patent/EP0682026B2/fr not_active Expired - Lifetime
- 1995-04-27 DE DE59507591T patent/DE59507591D1/de not_active Expired - Lifetime
- 1995-04-27 ES ES95106285T patent/ES2144066T5/es not_active Expired - Lifetime
- 1995-04-27 PT PT95106285T patent/PT682026E/pt unknown
- 1995-04-27 AT AT95106285T patent/ATE188699T1/de active
- 1995-05-02 JP JP10888195A patent/JP3419585B2/ja not_active Expired - Fee Related
- 1995-05-04 CA CA002148671A patent/CA2148671C/fr not_active Expired - Lifetime
- 1995-05-05 RU RU95107144/04A patent/RU2165422C2/ru active
- 1995-05-08 CN CN95106005A patent/CN1063444C/zh not_active Expired - Lifetime
- 1995-05-08 HU HU9501348A patent/HUT71612A/hu unknown
- 1995-05-08 NO NO19951796A patent/NO313673B1/no not_active IP Right Cessation
- 1995-05-08 FI FI952198A patent/FI120585B/fi not_active IP Right Cessation
- 1995-05-08 ZA ZA953673A patent/ZA953673B/xx unknown
- 1995-05-08 AU AU17931/95A patent/AU704363B2/en not_active Ceased
- 1995-05-09 KR KR1019950011214A patent/KR950032192A/ko not_active Ceased
-
1998
- 1998-01-26 US US09/013,266 patent/US6271374B1/en not_active Expired - Lifetime
-
2000
- 2000-03-16 GR GR20000400684T patent/GR3032984T3/el not_active IP Right Cessation
-
2001
- 2001-01-08 US US09/755,072 patent/US6596721B2/en not_active Expired - Fee Related
-
2003
- 2003-01-28 JP JP2003019261A patent/JP4898081B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA953673B (en) | Stable crystalline (6S)- and (6R)- tetrahydrofolic acid | |
| AU1803092A (en) | 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
| AU591745B2 (en) | 2-cyanoacrylate composition | |
| AU1071288A (en) | Polyolefin stabilising composition | |
| AU1739192A (en) | 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives | |
| FI920180L (fi) | Foerfarande foer framstaellning av (6s) - och (6r)-tetrahydrofolsyra. | |
| AU5184193A (en) | Diaminobenzoic acid derivatives | |
| AU2156088A (en) | Arylenediamino substituted triazine | |
| AU2052188A (en) | Toothbrush for controlling brushing-stroke | |
| AU2030988A (en) | Pyrimidine derivatives | |
| AU646762B2 (en) | Cyclic-substituted imidazolyl-propenoic acid derivatives | |
| AU646977B2 (en) | Imidazolyl-propenoic acid derivatives | |
| AU4791993A (en) | Diamino acid derivatives as antihypertensives | |
| AU7273187A (en) | Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives | |
| AU3057192A (en) | Method for extending produce shelf life | |
| AU2979892A (en) | Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives | |
| AU2065688A (en) | Rifamycin derivatives | |
| AU2294088A (en) | Can carrier composition | |
| AU580186B2 (en) | Rubber-modified nylon composition | |
| AU1116692A (en) | Lampholder | |
| AU1980888A (en) | Toothbrush | |
| GB8811237D0 (en) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives | |
| AU2700988A (en) | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents | |
| EP0548895A3 (en) | Process for the preparation of pure diasteroisomers of tetrahydrofolates | |
| AU638486B2 (en) | Opposed spindles lathe |